KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Other Working Capital Changes: 2015-2025

Historic Other Working Capital Changes for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to -$100.6 million.

  • BeOne Medicines' Other Working Capital Changes fell 385.41% to -$100.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$111.9 million, marking a year-over-year increase of 34.76%. This contributed to the annual value of -$45.1 million for FY2024, which is 82.34% up from last year.
  • As of Q3 2025, BeOne Medicines' Other Working Capital Changes stood at -$100.6 million, which was down 233.99% from $75.1 million recorded in Q2 2025.
  • Over the past 5 years, BeOne Medicines' Other Working Capital Changes peaked at $150.2 million during Q1 2021, and registered a low of -$381.4 million during Q4 2021.
  • Moreover, its 3-year median value for Other Working Capital Changes was -$25.2 million (2024), whereas its average is -$35.6 million.
  • The largest annual percentage gain for BeOne Medicines' Other Working Capital Changes in the last 5 years was 316.48% (2021), contrasted with its biggest fall of 14,005.47% (2021).
  • Over the past 5 years, BeOne Medicines' Other Working Capital Changes (Quarterly) stood at -$381.4 million in 2021, then soared by 89.78% to -$39.0 million in 2022, then tumbled by 407.19% to -$183.0 million in 2023, then spiked by 88.68% to -$56.6 million in 2024, then crashed by 385.41% to -$100.6 million in 2025.
  • Its Other Working Capital Changes was -$100.6 million in Q3 2025, compared to $75.1 million in Q2 2025 and -$29.7 million in Q1 2025.